This invention relates to arthroscopic tissue cutting and removal devices by which anatomical tissues may be cut and removed from a joint or other site. More specifically, this invention relates to instruments configured for cutting and removing bone or other hard tissue and having a ceramic cutting member.
In several surgical procedures including subacromial decompression, anterior cruciate ligament reconstruction involving notchplasty, and arthroscopic resection of the acromioclavicular joint, there is a need for cutting and removal of bone and soft tissue. Currently, surgeons use arthroscopic shavers and burrs having rotational cutting surfaces to remove tissue for such procedures. A typical arthroscopic shaver or burr comprises a metal cutting member carried at the distal end of a metal sleeve that rotates within an open-ended metal shaft. A suction pathway for removal of bone fragments or other tissues is provided through a window proximal to the metal cutting member that communicates with a lumen in the sleeve.
When metal shavers and burrs “wear” during a procedure, which occurs very rapidly when cutting bone, the wear can be accompanied by loss of micro-particles from fracture and particle release which occurs along with dulling due to metal deformation. In such surgical applications, even very small amounts of such foreign particles that are not recovered from a treatment site can lead to detrimental effects on the patient health, with inflammation being typical. In some cases, the foreign particles can result in joint failure due to osteolysis, a term used to define inflammation due to presence of such foreign particles. A recent article describing such foreign particle induced inflammation is Pedowitz, et al. (2013) Arthroscopic surgical tools: “A source of metal particles and possible joint damage”, Arthroscopy—The Journal of Arthroscopic and Related Surgery, 29(9), 1559-1565. In addition to causing inflammation, the presence of metal particles in a joint or other treatment site can cause serious problems for future MRIs. Typically, the MRI images will be blurred by agitation of the metal particles caused by the magnetic field used in the imaging, making assessments of the treatment difficult.
Another problem with the currently available metal shavers/burrs relates to manufacturing limitations in combination with the rapid dulling of metal cutting edges. Typically, a metal cutter is manufactured by machining the cutting surfaces and flutes into a burr or abrader surface. The flute shape and geometry can be limited since it is dictated by the machining process, and burr size and shape limitations may direct usage toward more coarse bone removal applications. Further, when operated in a rotational or oscillatory mode, the cutting edges adapted for coarse bone removal may have a kickback effect as the flutes first make contact with bone, which is aggravated by rapid dulling of the machined cutting edges.
Therefore, the need exists for arthroscopic burrs and/or shavers that can operate to cut and remove bone without the release of fractured particles and micro-particles into the treatment site. Further, there is a need for burrs/cutters that do not wear rapidly and that can have cutting edges not limited by metal machining techniques.
As an alternative to such arthroscopic cutters and shavers, another class of tissue removal tools relies on radiofrequency (RF) ablation to remove the soft tissue. Tools such as those described in U.S. Pat. Nos. 6,149,620 and 7,678,069 can be highly effective in volumetric removal of soft tissue in the knee and elsewhere but are ineffective in resecting bone.
Therefore, the need exists for tools that can effectively remove both bone and soft tissue and which can combine the advantages of both cutter-based hard tissue resection and RF-based soft tissue ablation. At least some of these objectives will be met by the inventions described below.
The present invention provides a variety of improved tissue removal devices and methods, including devices and methods which can remove tissue by cutting (resection) and/or by radiofrequency (RF) ablation.
In a first specific aspect of the present invention, a medical device for removing tissue includes an elongated sleeve having a longitudinal axis, a proximal end, and a distal end. A ceramic cutting member with at least one cutting edge extends distally from the distal end of the elongated sleeve, and an electrode is carried by the cutting member. A motor drive is configured to couple to the proximal end of elongated sleeve to rotate the cutting member. In some embodiments, the elongated sleeve is an inner sleeve and is coaxially and rotatably disposed in an outer sleeve, where the outer sleeve may have a cut-out to expose the ceramic cutting member and the electrode.
The cutting edge of medical device for removing tissue will have a radially outward rotational periphery which is at least as great as an outward rotational periphery of the electrode, and the dielectric material typically comprises a wear-resistant ceramic material, usually consisting exclusively of the wear-resistant ceramic material. Exemplary wear-resistant ceramic materials are selected from the group consisting of yttria-stabilized zirconia, magnesia-stabilized zirconia, ceria-stabilized zirconia, zirconia toughened alumina and silicon nitride. The medical device will typically further comprise an RF source connected to the electrode and a controller operatively connectable to the motor drive, the RF source, and a negative pressure source.
The cutting member of the medical device will often have at least one window in a side thereof which communicates with an interior channel of the elongated (inner) sleeve which is configured to be connected to a negative pressure source. The window is typically adjacent to the electrode so that material released by resection and/or ablation can be aspirated through said window. The window optionally can be used for fluid infusion for use in electrosurgery. In some instances, the window is proximal to the electrode and/or proximal to the cutting edges, an/or at least partly intermediate the cutting edges. The cutting member may have from 1 to 100 cutting edges, a diameter ranging between 2 mm and 10 mm, and may extend over an axial length ranging between 1 mm and 10 mm. The cutting edges may be arranged in a pattern selected from at least one of helical, angled and straight relative to said axis.
In a second specific aspect of the present invention, a medical system for removing tissue includes an elongated rotatable shaft with a distal tip comprising (or composed of) a ceramic material. A motor drive is configured to rotate the shaft and the distal tip, and an electrode is carried by the distal tip. The electrode is coupled to an RF source, and a controller is operatively connected to the motor drive and to the RF source. The controller is configured to stop rotation of the shaft in a selected position, such as a position that will expose the electrode in a position that allows it to be used for ablative or other tissue treatment.
The medical device may further include a sensor configured to sense a rotational position of the shaft and to send signals to the controller indicating said rotational position. The controller may be configured to stop rotation of the shaft in the selected or other position, for example when a portion of distal tip such as the electrode or cutter element is properly oriented to perform a desired ablation, resection, or other treatment. The sensor is usually a Hall sensor. The controller may be further configured to control delivery of RF energy to the electrode when the shaft in said selected position. The distal tip of the rotatable shaft may have at least one window in a side thereof that opens to an interior channel in the shaft where the channel is configured to communicate with a negative pressure source. The window may be adjacent the electrode and/or may be at least partly proximal to the electrode. The distal tip may comprise or consist entirely of a wear-resistant ceramic material, such as those listed elsewhere herein.
In a third specific aspect of the present invention, a medical device for removing tissue includes an elongated shaft with a distal tip having a ceramic member. A window in the ceramic member connects to an interior channel in the shaft, and an electrode in the ceramic member is positioned adjacent to a distal end of the window. The interior channel is configured to be coupled to a negative pressure source.
The electrode may have a width equal to at least 50% of a width of the window, sometimes being at least 80% of the width of the window, and sometimes being at least 100% of the width of the window, or greater. At least one side of the window may have a sharp edge, and the electrode may at least partly encircle the distal end of the window. The ceramic member may have at least one sharp edge for cutting tissue, and a radially outward surface of the ceramic member usually defines a cylindrical periphery with an outward surface of the electrode being within said cylindrical periphery. The ceramic member will usually have at least one and more usually a plurality of sharp edges for cutting tissue.
In a fourth specific aspect of the present invention, a method for electrosurgical tissue ablation comprises providing an elongated shaft with a working end including an active electrode carried adjacent to a window that opens to an interior channel in the shaft. The channel is connected to a negative pressure source, and the active electrode and window are positioned in contact with target tissue in a fluid-filled space. The negative pressure source may be activated to suction the target tissue into the window, and the active electrode is activated (typically to deliver RF energy) to ablate tissue while translating the working end relative to the targeted tissue.
In specific aspects of the methods, a motor drive rotates the shaft and the distal tip (typically at at least 3,000 rpm), and a controller operatively connects the interior channel to the negative pressure source and an RF source to the electrode. The ceramic member is a wear-resistant material, typically as noted previously herein. Tissue debris is aspirated through the interior channel, and the working end is translated to remove a surface portion of the targeted tissue and/or to undercut the targeted tissue to thereby remove chips of tissue.
In still further aspects, the present invention provides a high-speed rotating cutter or burr that is fabricated entirely of a ceramic material. In one variation, the ceramic is a molded monolith with sharp cutting edges and is adapted to be motor driven at speeds ranging from 3,000 rpm to 20,000 rpm. The ceramic cutting member is coupled to an elongate inner sleeve that is configured to rotate within a metal, ceramic or composite outer sleeve. The ceramic material is exceptionally hard and durable and will not fracture and thus not leave foreign particles in a treatment site. In one aspect, the ceramic has a hardness of at least 8 GPa (kg/mm2) and a fracture toughness of at least 2 MPam1/2. The “hardness” value is measured on a Vickers scale and “fracture toughness” is measured in MPam1/2. Fracture toughness refers to a property which describes the ability of a material containing a flaw to resist further fracture and expresses a material's resistance to such fracture. In another aspect, it has been found that materials suitable for the cutting member of the invention have a certain hardness-to-fracture toughness ratio, which is a ratio of at least 0.5 to 1
While the cutting assembly and ceramic cutting member of the invention have been designed for arthroscopic procedures, such devices can be fabricated in various cross-sections and lengths and can be use in other procedures for cutting bone, cartilage and soft tissue such as in ENT procedures, spine and disc procedures and plastic surgeries.
In another aspect, the present invention provides a medical device that includes an elongated sleeve having a longitudinal axis, a proximal end and a distal end. A cutting member extends distally from the distal end of the elongated sleeve, and has sharp cutting edges. The cutting head is formed from a wear-resistant ceramic material, and a motor coupled to the proximal end of elongated sleeve rotates the cutting member. The cutter may be engaged against bone and rotated to cut bone tissue without leaving any foreign particles in the site.
The wear-resistant ceramic material may comprise any one or combination of (1) zirconia, (2) a material selected from the group of yttria-stabilized zirconia, magnesia-stabilized zirconia and zirconia toughened alumina, or (3) silicon nitride. The cutting member typically has from 2 to 100 cutting edges, a cylindrical periphery, and is usually rounded in the distal direction. The cutting member will typically have diameter ranging from 2 mm to 10 mm, and the cutting edges will typically extend over an axial length ranging between 1 mm and 10 mm. The cutting edges may be any one of helical, angled or straight relative to said axis, and flutes between the cutting edges usually have a depth ranging from 0.10 mm to 2.5 mm. An aspiration tube may be configured to connect to a negative pressure source, where the cutting member has at least one window in a side thereof which opens to a hollow interior. In these embodiments, the hollow interior is open to a central passage of the elongated member which is connected to the aspiration tube.
In a further aspect, the present invention provides a medical device for treating bone including an elongated shaft having a longitudinal axis, a proximal end, and a distal end. A monolithic cutting member fabricated of a material having a hardness of at least 8 GPa (kg/mm2) is coupled to the distal end of the elongated shaft, and a motor is operatively connected to the proximal end of the shaft, said motor being configured to rotate the shaft at at least 3,000 rpm.
The material usually has a fracture toughness of at least 2 MPam1/2, and further usually has a coefficient of thermal expansion of less than 10 (1×106/° C.). The material typically comprises a ceramic selected from the group of yttria-stabilized zirconia, magnesia-stabilized zirconia, ceria-stabilized zirconia, zirconia toughened alumina and silicon nitride, and the cutting member typically has a cylindrical periphery and an at least partly rounded periphery in an axial direction.
In a still further aspect, the present invention provides a medical device for treating bone comprising a monolithic cutting member fabricated of a material having a hardness-to-fracture toughness ratio of at least 0.5:1, usually at least 0.8:1, and often at least 1:1.
In yet another aspect, the present invention provides a medical device for cutting tissue including a motor-driven shaft having a longitudinal axis, a proximal end, a distal end, and a lumen extending therebetween. A rotatable cutting member is fabricated entirely of a ceramic material and is operatively coupled to the distal end of the motor-driven shaft. At least one window in the cutting member communicates with the lumen in the shaft, and a negative pressure source is in communication with the lumen to remove cut tissue from an operative site.
The ceramic material typically has a hardness of at least 8 GPa (kg/mm2) and a fracture toughness of at least 2 MPam1/2. Additionally, the ceramic material will usually have a coefficient of thermal expansion of less than 10 (1×106° C.). Exemplary ceramic materials are selected from the group consisting of yttria-stabilized zirconia, magnesia-stabilized zirconia, ceria-stabilized zirconia, zirconia toughened alumina and silicon nitride, and the cutting member usually has cutting edges where the at least one window is proximate to the cutting edges, and the at least one window is in at least one flute between the cutting edges.
In another aspect, the present invention provides a method for preventing foreign particle induced inflammation at a bone treatment site. A rotatable cutter fabricated of a ceramic material having a hardness of at least 8 GPa (kg/mm2) and a fracture toughness of at least 2 MPam1/2 is engaged against bone and rotated to cut bone tissue without leaving any foreign particles in the site.
The ceramic material is usually selected from the group consisting of yttria-stabilized zirconia, magnesia-stabilized zirconia, ceria-stabilized zirconia, zirconia toughened alumina and silicon nitride, and the cutter is typically rotated at 10,000 rpm or greater. Cut bone tissue is removed from the bone treatment site through a channel in the cutter, typically by aspirating the cut bone tissue through the channel.
Various embodiments of the present invention will now be discussed with reference to the appended drawings. It should be appreciated that the drawings depict only typical embodiments of the invention and are therefore not to be considered limiting in scope.
The present invention relates to bone cutting and removal devices and related methods of use. Several variations of the invention will now be described to provide an overall understanding of the principles of the form, function and methods of use of the devices disclosed herein. In general, the present disclosure provides for an arthroscopic cutter or burr assembly for cutting or abrading bone that is disposable and is configured for detachable coupling to a non-disposable handle and motor drive component. This description of the general principles of this invention is not meant to limit the inventive concepts in the appended claims.
In general, the present invention provides a high-speed rotating ceramic cutter or burr that is configured for use in many arthroscopic surgical applications, including but not limited to treating bone in shoulders, knees, hips, wrists, ankles and the spine. More in particular, the device includes a cutting member that is fabricated entirely of a ceramic material that is extremely hard and durable, as described in detail below. A motor drive is operatively coupled to the ceramic cutter to rotate the burr edges at speeds ranging from 3,000 rpm to 20,000 rpm.
In one variation shown in
The cutter assembly 100 has a shaft 110 extending along longitudinal axis 115 that comprises an outer sleeve 120 and an inner sleeve 122 rotatably disposed therein with the inner sleeve 122 carrying a distal ceramic cutting member 125. The shaft 110 extends from a proximal hub assembly 128 wherein the outer sleeve 120 is coupled in a fixed manner to an outer hub 140A which can be an injection molded plastic, for example, with the outer sleeve 120 insert molded therein. The inner sleeve 122 is coupled to an inner hub 140B (phantom view) that is configured for coupling to the motor drive unit 105 (
Referring to
In
Now referring to
The authors evaluated technical ceramic materials and tested prototypes to determine which ceramics are best suited for the non-metal cutting member 125. When comparing the material hardness of the ceramic cutters of the invention to prior art metal cutters, it can easily be understood why typical stainless steel bone burrs are not optimal. Types 304 and 316 stainless steel have hardness ratings of 1.7 and 2.1, respectively, which is low and a fracture toughness ratings of 228 and 278, respectively, which is very high. Human bone has a hardness rating of 0.8, so a stainless steel cutter is only about 2.5 times harder than bone. The high fracture toughness of stainless steel provides ductile behavior which results in rapid cleaving and wear on sharp edges of a stainless steel cutting member. In contrast, technical ceramic materials have a hardness ranging from approximately 10 to 15, which is five to six times greater than stainless steel and which is 10 to 15 times harder than cortical bone. As a result, the sharp cutting edges of a ceramic remain sharp and will not become dull when cutting bone. The fracture toughness of suitable ceramics ranges from about 5 to 13 which is sufficient to prevent any fracturing or chipping of the ceramic cutting edges. The authors determined that a hardness-to-fracture toughness ratio (“hardness-toughness ratio”) is a useful term for characterizing ceramic materials that are suitable for the invention as can be understood form the Chart A below, which lists hardness and fracture toughness of cortical bone, a 304 stainless steel, and several technical ceramic materials.
As can be seen in Chart A, the hardness-toughness ratio for the listed ceramic materials ranges from 98× to 250× greater than the hardness-toughness ratio for stainless steel 304. In one aspect of the invention, a ceramic cutter for cutting hard tissue is provided that has a hardness-toughness ratio of at least 0.5:1, 0.8:1 or 1:1.
In one variation, the ceramic cutting member 125 is a form of zirconia. Zirconia-based ceramics have been widely used in dentistry and such materials were derived from structural ceramics used in aerospace and military armor. Such ceramics were modified to meet the additional requirements of biocompatibility and are doped with stabilizers to achieve high strength and fracture toughness. The types of ceramics used in the current invention have been used in dental implants, and technical details of such zirconia-based ceramics can be found in Volpato, et al., “Application of Zirconia in Dentistry: Biological, Mechanical and Optical Considerations”, Chapter 17 in Advances in Ceramics—Electric and Magnetic Ceramics, Bioceramics, Ceramics and Environment (2011).
In one variation, the ceramic cutting member 125 is fabricated of an yttria-stabilized zirconia as is known in the field of technical ceramics, and can be provided by CoorsTek Inc., 16000 Table Mountain Pkwy., Golden, CO 80403 or Superior Technical Ceramics Corp., 600 Industrial Park Rd., St. Albans City, VT 05478. Other technical ceramics that may be used consist of magnesia-stabilized zirconia, ceria-stabilized zirconia, zirconia toughened alumina and silicon nitride. In general, in one aspect of the invention, the monolithic ceramic cutting member 125 has a hardness rating of at least 8 GPa (kg/mm2). In another aspect of the invention, the ceramic cutting member 125 has a fracture toughness of at least 2 MPam1/2.
The fabrication of such ceramics or monoblock components are known in the art of technical ceramics, but have not been used in the field of arthroscopic or endoscopic cutting or resecting devices. Ceramic part fabrication includes molding, sintering and then heating the molded part at high temperatures over precise time intervals to transform a compressed ceramic powder into a ceramic monoblock which can provide the hardness range and fracture toughness range as described above. In one variation, the molded ceramic member part can have additional strengthening through hot isostatic pressing of the part. Following the ceramic fabrication process, a subsequent grinding process optionally may be used to sharpen the cutting edges 175 of the burr (see
In
Referring to
It can be understood that the ceramic cutting members can eliminate the possibility of leaving metal particles in a treatment site. In one aspect of the invention, a method of preventing foreign particle induced inflammation in a bone treatment site comprises providing a rotatable cutter fabricated of a ceramic material having a hardness of at least 8 GPa (kg/mm2) and/or a fracture toughness of at least 2 MPam1/2 and rotating the cutter to cut bone without leaving any foreign particles in the treatment site. The method includes removing the cut bone tissue from the treatment site through an aspiration channel in a cutting assembly.
In the variation illustrated in
The active electrode arrangement 425 can consist of a single conductive metal element or a plurality of metal elements as shown in
As can be seen in
Another aspect of the invention is illustrated in
In general, the tissue resecting system comprises an elongated shaft with a distal tip comprising a ceramic member, a window in the ceramic member connected to an interior channel in the shaft and an electrode arrangement in the ceramic member positioned distal to the window and having a width that is at least 50% of the width W of the window, usually at least 80% of the width W of the window, and often at least 100% of the width W of the window, or greater. Further, the system includes a negative pressure source 160 in communication with the interior channel 420.
Now turning to
Under endoscopic vision, referring to
In general, a method corresponding to the invention includes providing an elongated shaft with a working end 400 comprising an active electrode 425 carried adjacent to a window 415 that opens to an interior channel in the shaft which is connected to a negative pressure source, positioning the active electrode and window in contact with targeted tissue in a fluid-filled space, activating the negative pressure source to thereby suction targeted tissue into the window and delivering RF energy to the active electrode to ablate tissue while translating the working end across the targeted tissue. The method further comprises aspirating tissue debris through the interior channel 420. In a method, the working end 400 is translated to remove a surface portion of the targeted tissue. In a variation of the method, the working end 400 is translated to undercut the targeted tissue to thereby remove chips 488 of tissue.
Now turning to
A number of embodiments of the invention have been described. Nevertheless, it will be understood that various modifications may be made without departing from the spirit and scope of the invention.
This application is a continuation of U.S. patent application Ser. No. 15/449,796, filed Mar. 3, 2017, now U.S. Pat. No. 10,327,842, which is a divisional of U.S. patent application Ser. No. 14/977,256, filed Dec. 21, 2015, now U.S. Pat. No. 9,603,656, which claims the benefit of provisional application 62/250,315, filed on Nov. 3, 2015, and of provisional application 62/245,796, filed on Oct. 23, 2015, the full disclosures of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
2513564 | Ingwersen | Jul 1950 | A |
2514545 | Ingwersen | Jul 1950 | A |
2625625 | Ingwersen | Jan 1953 | A |
2689895 | Ingwersen | Sep 1954 | A |
3611023 | Souza et al. | Oct 1971 | A |
3838242 | Goucher | Sep 1974 | A |
3848211 | Russell | Nov 1974 | A |
3868614 | Riendeau | Feb 1975 | A |
3903891 | Brayshaw | Sep 1975 | A |
4060088 | Morrison, Jr. et al. | Nov 1977 | A |
4272687 | Borkan | Jun 1981 | A |
4781175 | Mcgreevy et al. | Nov 1988 | A |
4895146 | Draenert | Jan 1990 | A |
4977346 | Gibson et al. | Dec 1990 | A |
5012495 | Munroe et al. | Apr 1991 | A |
5122138 | Manwaring | Jun 1992 | A |
5207675 | Canady | May 1993 | A |
5256138 | Burek et al. | Oct 1993 | A |
5281217 | Edwards et al. | Jan 1994 | A |
5449356 | Walbrink et al. | Sep 1995 | A |
5490854 | Fisher et al. | Feb 1996 | A |
5602449 | Krause et al. | Feb 1997 | A |
5641251 | Leins et al. | Jun 1997 | A |
5669907 | Platt, Jr. et al. | Sep 1997 | A |
5683366 | Eggers et al. | Nov 1997 | A |
5720745 | Farin et al. | Feb 1998 | A |
5759185 | Grinberg | Jun 1998 | A |
5766195 | Nobles | Jun 1998 | A |
5776092 | Farin et al. | Jul 1998 | A |
5810809 | Rydell | Sep 1998 | A |
5823971 | Robinson et al. | Oct 1998 | A |
5839897 | Bordes | Nov 1998 | A |
5849010 | Wurzer et al. | Dec 1998 | A |
5857995 | Thomas et al. | Jan 1999 | A |
5873855 | Eggers et al. | Feb 1999 | A |
5888198 | Eggers et al. | Mar 1999 | A |
5891095 | Eggers et al. | Apr 1999 | A |
5904681 | West, Jr. | May 1999 | A |
5913867 | Dion | Jun 1999 | A |
5964752 | Stone | Oct 1999 | A |
5989248 | Tu et al. | Nov 1999 | A |
6013075 | Avramenko et al. | Jan 2000 | A |
6013076 | Goble et al. | Jan 2000 | A |
6024733 | Eggers et al. | Feb 2000 | A |
6032674 | Eggers et al. | Mar 2000 | A |
6039736 | Platt, Jr. | Mar 2000 | A |
6056747 | Saadat et al. | May 2000 | A |
6066134 | Eggers et al. | May 2000 | A |
6099523 | Kim et al. | Aug 2000 | A |
6142992 | Cheng et al. | Nov 2000 | A |
6149620 | Baker et al. | Nov 2000 | A |
6159208 | Hovda et al. | Dec 2000 | A |
6210405 | Goble et al. | Apr 2001 | B1 |
6225883 | Wellner et al. | May 2001 | B1 |
6235020 | Cheng et al. | May 2001 | B1 |
6238391 | Olsen et al. | May 2001 | B1 |
6245084 | Mark et al. | Jun 2001 | B1 |
6261241 | Burbank et al. | Jul 2001 | B1 |
6296636 | Cheng et al. | Oct 2001 | B1 |
6332886 | Green | Dec 2001 | B1 |
6348051 | Farin et al. | Feb 2002 | B1 |
6358263 | Mark et al. | Mar 2002 | B2 |
6394956 | Chandrasekaran et al. | May 2002 | B1 |
6413256 | Truckai et al. | Jul 2002 | B1 |
6419674 | Bowser et al. | Jul 2002 | B1 |
6419684 | Heisler et al. | Jul 2002 | B1 |
6443948 | Suslov | Sep 2002 | B1 |
6475215 | Tanrisever | Nov 2002 | B1 |
6538549 | Renne et al. | Mar 2003 | B1 |
6579289 | Schnitzler | Jun 2003 | B2 |
6610059 | West, Jr. | Aug 2003 | B1 |
6632220 | Eggers et al. | Oct 2003 | B1 |
6656195 | Peters et al. | Dec 2003 | B2 |
6669694 | Shadduck | Dec 2003 | B2 |
6720856 | Pellon et al. | Apr 2004 | B1 |
6780178 | Palanker et al. | Aug 2004 | B2 |
6783533 | Green et al. | Aug 2004 | B2 |
6821275 | Truckai et al. | Nov 2004 | B2 |
6837884 | Woloszko | Jan 2005 | B2 |
6890332 | Truckai et al. | May 2005 | B2 |
6902564 | Morgan et al. | Jun 2005 | B2 |
6979332 | Adams | Dec 2005 | B2 |
7087054 | Truckai et al. | Aug 2006 | B2 |
7150747 | Mcdonald et al. | Dec 2006 | B1 |
7220261 | Truckai et al. | May 2007 | B2 |
7309849 | Truckai et al. | Dec 2007 | B2 |
7549989 | Morgan et al. | Jun 2009 | B2 |
7674263 | Ryan | Mar 2010 | B2 |
7678069 | Baker et al. | Mar 2010 | B1 |
7713269 | Auge, II et al. | May 2010 | B2 |
7717710 | Danger et al. | May 2010 | B2 |
7744595 | Truckai et al. | Jun 2010 | B2 |
7771422 | Auge, II et al. | Aug 2010 | B2 |
7819861 | Auge, II et al. | Oct 2010 | B2 |
7819864 | Morgan et al. | Oct 2010 | B2 |
7842009 | Torrance | Nov 2010 | B2 |
7955331 | Truckai et al. | Jun 2011 | B2 |
8012153 | Woloszko et al. | Sep 2011 | B2 |
8016823 | Shadduck | Sep 2011 | B2 |
8062319 | Oquinn et al. | Nov 2011 | B2 |
8075555 | Truckai et al. | Dec 2011 | B2 |
8192424 | Woloszko | Jun 2012 | B2 |
8192428 | Truckai et al. | Jun 2012 | B2 |
8221404 | Truckai | Jul 2012 | B2 |
8323280 | Germain et al. | Dec 2012 | B2 |
8333763 | Truckai et al. | Dec 2012 | B2 |
8372068 | Truckai | Feb 2013 | B2 |
8486096 | Robertson et al. | Jul 2013 | B2 |
8702702 | Edwards et al. | Apr 2014 | B1 |
9179923 | Gubellini et al. | Nov 2015 | B2 |
9204918 | Germain et al. | Dec 2015 | B2 |
9277954 | Germain et al. | Mar 2016 | B2 |
9504521 | Deutmeyer et al. | Nov 2016 | B2 |
9585675 | Germain et al. | Mar 2017 | B1 |
9592085 | Germain et al. | Mar 2017 | B2 |
9603656 | Germain et al. | Mar 2017 | B1 |
9681913 | Orczy-timko et al. | Jun 2017 | B2 |
9795434 | Germain et al. | Oct 2017 | B2 |
10004556 | Orczy-Timko et al. | Jun 2018 | B2 |
10022140 | Germain et al. | Jul 2018 | B2 |
10327842 | Germain et al. | Jun 2019 | B2 |
10568685 | Germain et al. | Feb 2020 | B2 |
10582966 | Orczy-timko et al. | Mar 2020 | B2 |
11234759 | Germain et al. | Feb 2022 | B2 |
11419670 | Germain et al. | Aug 2022 | B2 |
20020007190 | Wulfman | Jan 2002 | A1 |
20020038129 | Peters | Mar 2002 | A1 |
20030014051 | Woloszko | Jan 2003 | A1 |
20030083681 | Moutafis | May 2003 | A1 |
20030125727 | Truckai et al. | Jul 2003 | A1 |
20030163135 | Hathaway | Aug 2003 | A1 |
20040044341 | Truckai et al. | Mar 2004 | A1 |
20040167427 | Quick et al. | Aug 2004 | A1 |
20050075630 | Truckai et al. | Apr 2005 | A1 |
20050228372 | Truckai et al. | Oct 2005 | A1 |
20060058782 | Truckai et al. | Mar 2006 | A1 |
20060074345 | Hibner | Apr 2006 | A1 |
20060178670 | Woloszko et al. | Aug 2006 | A1 |
20060200123 | Ryan | Sep 2006 | A1 |
20060224154 | Shadduck et al. | Oct 2006 | A1 |
20070213704 | Truckai et al. | Sep 2007 | A1 |
20080003255 | Kerr et al. | Jan 2008 | A1 |
20080103494 | Rioux et al. | May 2008 | A1 |
20080188848 | Deutmeyer et al. | Aug 2008 | A1 |
20080208249 | Blain et al. | Aug 2008 | A1 |
20090048485 | Heisler | Feb 2009 | A1 |
20090076498 | Saadat et al. | Mar 2009 | A1 |
20090270849 | Truckai et al. | Oct 2009 | A1 |
20100100091 | Truckai | Apr 2010 | A1 |
20100305565 | Truckai et al. | Dec 2010 | A1 |
20110004215 | Bradley et al. | Jan 2011 | A1 |
20110282373 | Chekan et al. | Nov 2011 | A1 |
20120209112 | Patel et al. | Aug 2012 | A2 |
20120245580 | Germain et al. | Sep 2012 | A1 |
20120330292 | Shadduck et al. | Dec 2012 | A1 |
20130122461 | Shioiri | May 2013 | A1 |
20130172870 | Germain et al. | Jul 2013 | A1 |
20130267937 | Shadduck et al. | Oct 2013 | A1 |
20130296847 | Germain et al. | Nov 2013 | A1 |
20130296849 | Germain et al. | Nov 2013 | A1 |
20130317493 | Truckai et al. | Nov 2013 | A1 |
20130331833 | Bloom | Dec 2013 | A1 |
20130345704 | Palmer | Dec 2013 | A1 |
20140100567 | Edwards | Apr 2014 | A1 |
20140135806 | Shener-irmakoglu et al. | May 2014 | A1 |
20140336643 | Orczy-timko et al. | Nov 2014 | A1 |
20150173827 | Bloom | Jun 2015 | A1 |
20150245862 | Goode et al. | Sep 2015 | A1 |
20150265337 | Bloom | Sep 2015 | A1 |
20160346036 | Orczy-Timko et al. | Dec 2016 | A1 |
20170128083 | Germain et al. | May 2017 | A1 |
20170172648 | Germain et al. | Jun 2017 | A1 |
20180263649 | Germain et al. | Sep 2018 | A1 |
20180303509 | Germain et al. | Oct 2018 | A1 |
20190015151 | Germain et al. | Jan 2019 | A1 |
20200060752 | Germain et al. | Feb 2020 | A1 |
20200163710 | Germain et al. | May 2020 | A1 |
Number | Date | Country |
---|---|---|
104093374 | Oct 2014 | CN |
108601612 | Sep 2018 | CN |
102005059864 | Jun 2007 | DE |
1034747 | Sep 2000 | EP |
3364899 | Aug 2018 | EP |
2002509756 | Apr 2002 | JP |
2015180290 | Oct 2015 | JP |
2018534057 | Nov 2018 | JP |
WO-9949799 | Oct 1999 | WO |
WO-0053112 | Sep 2000 | WO |
WO-0062685 | Oct 2000 | WO |
WO-0053112 | Dec 2000 | WO |
WO-0124720 | Apr 2001 | WO |
WO-2007073867 | Jul 2007 | WO |
WO-2013052250 | Apr 2013 | WO |
WO-2016171963 | Oct 2016 | WO |
WO-2017070486 | Apr 2017 | WO |
WO-2017070510 | Apr 2017 | WO |
WO-2017136414 | Aug 2017 | WO |
Entry |
---|
“U.S. Appl. No. 14/960,084, Examiner Interview Summary dated Aug. 9, 2016”, 3 pgs. |
“U.S. Appl. No. 14/960,084, Final Office Action dated Aug. 18, 2016”, 15 pgs. |
“U.S. Appl. No. 14/960,084, Non Final Office Action dated May 3, 2016”, 12 pgs. |
“U.S. Appl. No. 14/960,084, Notice of Allowance dated Jan. 6, 2017”, 7 pgs. |
“U.S. Appl. No. 14/960,084, Response filed Jun. 30, 2016 to Non Final Office Action dated May 3, 2016”, 11 pgs. |
“U.S. Appl. No. 14/960,084, Response filed Sep. 19, 2016 to Final Office Action dated Aug. 18, 2016”, 9 pgs. |
“U.S. Appl. No. 14/960,084, Supplemental Amendment filed Jul. 28, 2016”, 7 pgs. |
“U.S. Appl. No. 14/977,256, Corrected Notice of Allowability dated Dec. 30, 2016”, 7 pgs. |
“U.S. Appl. No. 14/977,256, Examiner Interview Summary dated Nov. 8, 2016”, 4 pgs. |
“U.S. Appl. No. 14/977,256, Non Final Office Action dated Jul. 28, 2016”, 20 pgs. |
“U.S. Appl. No. 14/977,256, Notice of Allowance dated Feb. 8, 2017”, 7 pgs. |
“U.S. Appl. No. 14/977,256, Notice of Allowance dated Dec. 2, 2016”, 12 pgs. |
“U.S. Appl. No. 14/977,256, Notice of Allowance dated Dec. 30, 2016”. |
“U.S. Appl. No. 14/977,256, Response filed Oct. 14, 2016 to Non Final Office Action dated Jul. 28, 2016”, 10 pgs. |
“U.S. Appl. No. 14/977,256, Supplemental Amendment filed Nov. 7, 2016”, 6 pgs. |
“U.S. Appl. No. 15/096,546, Non Final Office Action dated Sep. 26, 2016”, 20 pgs. |
“U.S. Appl. No. 15/096,546, Notice of Allowance dated Feb. 16, 2017”, 12 pgs. |
“U.S. Appl. No. 15/415,721, Final Office Action dated May 8, 2019”, 8 pgs. |
“U.S. Appl. No. 15/415,721, Non Final Office Action dated Dec. 12, 2018”, 9 pgs. |
“U.S. Appl. No. 15/415,721, Notice of Allowance dated Oct. 17, 2019”, 5 pgs. |
“U.S. Appl. No. 15/415,721, Preliminary Amendment filed May 31, 2017”, 6 pgs. |
“U.S. Appl. No. 15/415,721, Response filed Mar. 6, 2019 to Non Final Office Action dated Dec. 12, 2018”, 8 pgs. |
“U.S. Appl. No. 15/415,721, Response filed Oct. 1, 2019 to Final Office Action dated May 8, 2019”, 8 pgs. |
“U.S. Appl. No. 15/415,721, Response filed Nov. 27, 2018 to Restriction Requirement dated Aug. 30, 2018”, 1 pg. |
“U.S. Appl. No. 15/415,721, Restriction Requirement dated Aug. 30, 2018”, 9 pgs. |
“U.S. Appl. No. 15/421,264, Non Final Office Action dated Jul. 21, 2017”, 20 pgs. |
“U.S. Appl. No. 15/421,264, Notice of Allowance dated Mar. 19, 2018”, 14 pgs. |
“U.S. Appl. No. 15/449,796, Final Office Action dated Jul. 6, 2018”, 13 pgs. |
“U.S. Appl. No. 15/449,796, Non Final Office Action dated Nov. 3, 2017”, 10 pgs. |
“U.S. Appl. No. 15/449,796, Notice of Allowance dated Feb. 4, 2019”, 10 pgs. |
“U.S. Appl. No. 15/449,796, Notice of Allowance dated Mar. 7, 2019”, 6 pgs. |
“U.S. Appl. No. 15/449,796, Response filed Jan. 7, 2019 to Final Office Action dated Jul. 6, 2018”, 7 pgs. |
“U.S. Appl. No. 15/449,796, Response filed Jan. 17, 2018 to Non Final Office Action dated Nov. 3, 2017”, 6 pgs. |
“U.S. Appl. No. 15/449,796, Response filed Sep. 27, 2017 to Restriction Requirement dated Aug. 10, 2017”, 1 pgs. |
“U.S. Appl. No. 15/449,796, Restriction Requirement dated Aug. 10, 2017”, 8 pgs. |
“U.S. Appl. No. 15/599,372, Notice of Allowance dated Nov. 1, 2019”, 12 pgs. |
“U.S. Appl. No. 15/920,130, Non Final Office Action dated Apr. 27, 2020”, 8 pgs. |
“U.S. Appl. No. 16/406,656, Non Final Office Action dated Jun. 23, 2021”, 9 pgs. |
“U.S. Appl. No. 16/406,656, Notice of Allowance dated Sep. 24, 2021”, 8 pgs. |
“U.S. Appl. No. 16/406,656, Preliminary Amendment filed Nov. 14, 2019”, 4 pgs. |
“U.S. Appl. No. 16/406,656, Response filed Sep. 17, 2021 to Non Final Office Action dated Jun. 23, 2021”, 7 pgs. |
“U.S. Appl. No. 16/747,801, Restriction Requirement dated Dec. 8, 2021”, 8 pgs. |
“Chinese Application Serial No. 201680071192.2, Notification to Make Rectification dated Jun. 20, 2018”, (W/ English Translation), 2 pgs. |
“Chinese Application Serial No. 201680071192.2, Office Action dated Apr. 12, 2021”, with English translation, 14 pages. |
“Chinese Application Serial No. 201680071192.2, Office Action dated Jun. 2, 2020”, (W/ English Translation), 9 pgs. |
“Chinese Application Serial No. 201680071192.2, Response filed May 27, 2021 to Office Action dated Apr. 12, 2021”, (W/ English Translation of Claims), 13 pgs. |
“Co-pending U.S. Appl. No. 15/421,264, filed Jan. 31, 2017”. |
“Co-pending U.S. Appl. No. 15/449,796, filed Mar. 3, 2017”. |
“Co-pending U.S. Appl. No. 15/599,372, filed May 18, 2017”. |
“Co-pending U.S. Appl. No. 15/855,684, filed Dec. 27, 2017”. |
“Co-pending U.S. Appl. No. 16/747,801, filed Jan. 21, 2020”. |
“European Application Serial No. 01967968.7, Extended European Search Report dated Nov. 2, 2009”, 5 pgs. |
“European Application Serial No. 16858321.9, Extended European Search Report dated May 15, 2019”, 6 pgs. |
“European Application Serial No. 16858321.9, Response filed Sep. 24, 2019 to Extended European Search Report dated May 15, 2019”, 8 pgs. |
“European Application Serial No. 17748056.3, Extended European Search Report dated Jul. 12, 2019”, 8 pgs. |
“International Application Serial No. PCT/US2001/025409, International Search Report dated Jan. 14, 2002”, 1 pg. |
“International Application Serial No. PCT/US2001/025409, Written Opinion dated Jan. 14, 2002”, 1 page. |
“International Application Serial No. PCT/US2012/023390, International Search Report dated May 23, 2012”, 2 pgs. |
“International Application Serial No. PCT/US2012/023390, Written Opinion dated May 23, 2012”, 6 pgs. |
“International Application Serial No. PCT/US2016/027157, International Search Report dated Jul. 15, 2016”, 2 pgs. |
“International Application Serial No. PCT/US2016/027157, Written Opinion dated Jul. 15, 2016”, 7 pgs. |
“International Application Serial No. PCT/US2016/058145, International Preliminary Report on Patentability dated May 3, 2018”, 8 pgs. |
“International Application Serial No. PCT/US2016/058145, International Search Report dated Nov. 29, 2016”, 3 pgs. |
“International Application Serial No. PCT/US2016/058145, Written Opinion dated Nov. 29, 2016”, 6 pgs. |
“International Application Serial No. PCT/US2016/058179, International Preliminary Report on Patentability dated May 3, 2018”, 9 pgs. |
“International Application Serial No. PCT/US2016/058179, International Search Report dated Mar. 8, 2017”, 4 pgs. |
“International Application Serial No. PCT/US2016/058179, Written Opinion dated Mar. 8, 2017”, 7 pgs. |
“International Application Serial No. PCT/US2017/016002, International Search Report dated May 16, 2017”, 4 pgs. |
“International Application Serial No. PCT/US2017/016002, Written Opinion dated May 16, 2017”, 6 pgs. |
“Japanese Application Serial No. 2018-521293, Notification of Reasons for Refusal dated Apr. 2, 2021”, (W/ English Translation), 6 pgs. |
“Japanese Application Serial No. 2018-521293, Notification of Reasons for Refusal dated Sep. 8, 2020”, with English translation, 6 pages. |
“Japanese Application Serial No. 2018-521293, Response filed Mar. 5, 2021 to Notification of Reasons for Refusal dated Sep. 8, 2020”, (W/ English Translation of Claims), 15 pgs. |
“Japanese Application Serial No. 2018-521293, Response filed May 31, 2021 to Notification of Reasons for Refusal dated Apr. 2, 2021”, (W/ English Translation of Claims), 9 pgs. |
Benedek, et al., “Co-pending U.S. Appl. No. 16/780,041, filed Feb. 3, 2020”. |
Germain, et al., “U.S. Appl. No. 14/960,084, filed Dec. 4, 2015”. |
Germain, et al., “U.S. Appl. No. 14/977,256, filed Dec. 21, 2015”. |
Kim, et al., “Optical feedback signal for ultra short pulse ablation of tissue”, Appl. Surface Sci., (1998), 127-129:857-862. |
Pedowitz, et al., “Arthroscopic surgical tools: a source of metal particles and possible joint damage”, Arthroscopy. 29(9), (2013), 1559-65. |
Tucker, et al., “Histologic characteristics of electrosurgical injuries”, J. Am. Assoc. Gyneco. Laproscopy 4(2), (1997), 857-862. |
Volpato, et al., “Application of Zirconia in Dentistry: Biological, Mechanical and Optical Considerations.”, Advances in ceramic—electric and magnetic ceramics, bioceramics, ceramics and environment, (Sep. 2011), 397-420. |
Volpato, et al., “Applications of Zirconia in Dentistry: Biological, Mechanical and Optical Considerations”, [Online] (retrieved from the internet on Dec. 5,2016) <URL=http://cdn.intechopen.com/pdfs-wm/18282.pdf>, especially Introduction (p. 397), and 6.1.1 Zirconia toughened alumina (ZT A) (p. 411 )., (Sep. 6, 2011). |
“U.S. Appl. No. 16/747,801, Non Final Office Action dated Feb. 11, 2022”, 9 pgs. |
“U.S. Appl. No. 16/747,801, Notice of Allowance dated Apr. 27, 2022”, 7 pgs. |
“U.S. Appl. No. 16/747,801, PTO Response to Rule 312 Communication dated Jul. 25, 2022”, 2 pgs. |
“U.S. Appl. No. 16/747,801, Response filed Feb. 2, 2022 to Restriction Requirement dated Dec. 8, 2021”, 6 pgs. |
“U.S. Appl. No. 16/747,801, Response filed Apr. 13, 2022 to Non Final Office Action dated Feb. 11, 2022”, 9 pgs. |
“European Application Serial No. 16858321.9, Communication Pursuant to Article 94(3) EPC dated May 23, 2022”, 4 pgs. |
Number | Date | Country | |
---|---|---|---|
20220175440 A1 | Jun 2022 | US |
Number | Date | Country | |
---|---|---|---|
62250315 | Nov 2015 | US | |
62245796 | Oct 2015 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14977256 | Dec 2015 | US |
Child | 15449796 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16406656 | May 2019 | US |
Child | 17554240 | US | |
Parent | 15449796 | Mar 2017 | US |
Child | 16406656 | US |